Literature DB >> 33445709

Mimicking Tumor Hypoxia in Non-Small Cell Lung Cancer Employing Three-Dimensional In Vitro Models.

Iwona Ziółkowska-Suchanek1.   

Abstract

Hypoxia is the most common microenvironment feature of lung cancer tumors, which affects cancer progression, metastasis and metabolism. Oxygen induces both proteomic and genomic changes within tumor cells, which cause many alternations in the tumor microenvironment (TME). This review defines current knowledge in the field of tumor hypoxia in non-small cell lung cancer (NSCLC), including biology, biomarkers, in vitro and in vivo studies and also hypoxia imaging and detection. While classic two-dimensional (2D) in vitro research models reveal some hypoxia dependent manifestations, three-dimensional (3D) cell culture models more accurately replicate the hypoxic TME. In this study, a systematic review of the current NSCLC 3D models that have been able to mimic the hypoxic TME is presented. The multicellular tumor spheroid, organoids, scaffolds, microfluidic devices and 3D bioprinting currently being utilized in NSCLC hypoxia studies are reviewed. Additionally, the utilization of 3D in vitro models for exploring biological and therapeutic parameters in the future is described.

Entities:  

Keywords:  hypoxia; in vitro models; lung cancer; three-dimensional; tumor microenvironment

Year:  2021        PMID: 33445709      PMCID: PMC7828188          DOI: 10.3390/cells10010141

Source DB:  PubMed          Journal:  Cells        ISSN: 2073-4409            Impact factor:   6.600


  109 in total

Review 1.  Targeting Hypoxia to Improve Non-Small Cell Lung Cancer Outcome.

Authors:  Ahmed Salem; Marie-Claude Asselin; Bart Reymen; Alan Jackson; Philippe Lambin; Catharine M L West; James P B O'Connor; Corinne Faivre-Finn
Journal:  J Natl Cancer Inst       Date:  2018-01-01       Impact factor: 13.506

Review 2.  Oxygen homeostasis.

Authors:  Gregg L Semenza
Journal:  Wiley Interdiscip Rev Syst Biol Med       Date:  2010 May-Jun

3.  ROR1-CAR T cells are effective against lung and breast cancer in advanced microphysiologic 3D tumor models.

Authors:  Lars Wallstabe; Claudia Göttlich; Lena C Nelke; Johanna Kühnemundt; Thomas Schwarz; Thomas Nerreter; Hermann Einsele; Heike Walles; Gudrun Dandekar; Sarah L Nietzer; Michael Hudecek
Journal:  JCI Insight       Date:  2019-09-19

4.  In vivo assessment of tumor hypoxia in lung cancer with 60Cu-ATSM.

Authors:  Farrokh Dehdashti; Mark A Mintun; Jason S Lewis; Jeffrey Bradley; Ramaswamy Govindan; Richard Laforest; Michael J Welch; Barry A Siegel
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-04-12       Impact factor: 9.236

5.  Comparisons among pimonidazole binding, oxygen electrode measurements, and radiation response in C3H mouse tumors.

Authors:  J A Raleigh; S C Chou; G E Arteel; M R Horsman
Journal:  Radiat Res       Date:  1999-05       Impact factor: 2.841

Review 6.  Targeting HIF-1 for cancer therapy.

Authors:  Gregg L Semenza
Journal:  Nat Rev Cancer       Date:  2003-10       Impact factor: 60.716

7.  Scaffold-based lung tumor culture on porous PLGA microparticle substrates.

Authors:  Aneetta E Kuriakose; Wenjing Hu; Kytai T Nguyen; Jyothi U Menon
Journal:  PLoS One       Date:  2019-05-31       Impact factor: 3.240

8.  MiR-210 promotes a hypoxic phenotype and increases radioresistance in human lung cancer cell lines.

Authors:  S Grosso; J Doyen; S K Parks; T Bertero; A Paye; B Cardinaud; P Gounon; S Lacas-Gervais; A Noël; J Pouysségur; P Barbry; N M Mazure; B Mari
Journal:  Cell Death Dis       Date:  2013-03-14       Impact factor: 8.469

9.  A Novel High-Throughput 3D Screening System for EMT Inhibitors: A Pilot Screening Discovered the EMT Inhibitory Activity of CDK2 Inhibitor SU9516.

Authors:  Kazuya Arai; Takanori Eguchi; M Mamunur Rahman; Ruriko Sakamoto; Norio Masuda; Tetsuya Nakatsura; Stuart K Calderwood; Ken-Ichi Kozaki; Manabu Itoh
Journal:  PLoS One       Date:  2016-09-13       Impact factor: 3.240

View more
  6 in total

1.  Multicellular tumor spheroids of LNCaP-Luc prostate cancer cells as in vitro screening models for cytotoxic drugs.

Authors:  Elodie Jouberton; Aurélien Voissiere; Frédérique Penault-Llorca; Florent Cachin; Elisabeth Miot-Noirault
Journal:  Am J Cancer Res       Date:  2022-03-15       Impact factor: 6.166

2.  Characterization of Oxygen Levels in an Uninfected and Infected Human Blood-Cerebrospinal-Fluid-Barrier Model.

Authors:  Alexander Martens; Nicole de Buhr; Hiroshi Ishikawa; Horst Schroten; Maren von Köckritz-Blickwede
Journal:  Cells       Date:  2022-01-04       Impact factor: 6.600

Review 3.  Clinical Application Perspectives of Lung Cancers 3D Tumor Microenvironment Models for In Vitro Cultures.

Authors:  Irena Wieleba; Kamila Wojas-Krawczyk; Paweł Krawczyk; Janusz Milanowski
Journal:  Int J Mol Sci       Date:  2022-02-18       Impact factor: 5.923

4.  Innovative Platform for the Advanced Online Monitoring of Three-Dimensional Cells and Tissue Cultures.

Authors:  Sebastian Kreß; Roland Schaller-Ammann; Jürgen Feiel; Joachim Wegener; Joachim Priedl; Wolf Dietrich; Cornelia Kasper; Dominik Egger
Journal:  Cells       Date:  2022-01-25       Impact factor: 6.600

Review 5.  Tumor organoids: applications in cancer modeling and potentials in precision medicine.

Authors:  Hanxiao Xu; Dechao Jiao; Aiguo Liu; Kongming Wu
Journal:  J Hematol Oncol       Date:  2022-05-12       Impact factor: 23.168

Review 6.  Biomedical Applications of Non-Small Cell Lung Cancer Spheroids.

Authors:  Julian M Rozenberg; Gleb I Filkov; Alexander V Trofimenko; Evgeny A Karpulevich; Vladimir D Parshin; Valery V Royuk; Marina I Sekacheva; Mikhail O Durymanov
Journal:  Front Oncol       Date:  2021-12-07       Impact factor: 6.244

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.